In Vivo SILAC-Based Proteomics Reveals Phosphoproteome Changes during Mouse Skin Carcinogenesis

Cell Reports

Volumn 3, Issue 2, 2013, Pages 552-566

  Zanivan, Sara ^a,b   Meves, Alexander ^a,c   Behrendt, Kristina ^d   Schoof, Erwin M ^e   Neilson, Lisa J ^b   Cox, Jürgen ^a   Tang, Hao R ^b   Kalna, Gabriela ^b   van Ree, Janine H ^c   van Deursen, Jan M ^c   Trempus, Carol S ^f   Machesky, Laura M ^b   Linding, Rune ^e   Wickström, Sara A ^d   Fässler, Reinhard ^a   Mann, Matthias ^a,g  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^c Mayo Clinic   (United States)

^d MAX PLANCK INSTITUTE FOR BIOLOGY OF AGEING   (Germany)

^e TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^f NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^g University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; P21 ACTIVATED KINASE 4; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CELL ADHESION; ENZYME ACTIVITY; GENE EXPRESSION; HEREDITY; IN VIVO STUDY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SKIN CANCER; SKIN CARCINOGENESIS; STABLE ISOTOPE LABELING WITH AMINO ACID IN CELL CULTURE; TUMOR GROWTH;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOWN-REGULATION; HUMANS; ISOTOPE LABELING; MICE; P21-ACTIVATED KINASES; PAPILLOMA; PHOSPHOPEPTIDES; PHOSPHORYLATION; PROTEIN KINASE C; PROTEOME; PROTEOMICS; SKIN; SKIN NEOPLASMS; SRC-FAMILY KINASES; TANDEM MASS SPECTROMETRY; TITANIUM; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 84874259874     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.01.003     Document Type: Article

References (66)

1. Abel E.L., Angel J.M., Kiguchi K., DiGiovanni J. Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat. Protoc. 2009, 4:1350-1362.
2. Alam H., Bhate A.V., Gangadaran P., Sawant S.S., Salot S., Sehgal L., Dange P.P., Chaukar D.A., D'cruz A.K., Kannanl S., et al. Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma. BMC Cancer 2012, 12:32.
3. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., et al. Gene ontology: tool for the unification of biology. Nat. Genet. 2000, 25:25-29. The Gene Ontology Consortium.
4. Cheepala S.B., Yin W., Syed Z., Gill J.N., McMillian A., Kleiner H.E., Lynch M., Loganantharaj R., Trutschl M., Cvek U., Clifford J.L. Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion. Mol. Cancer 2009, 8:27.
5. Chong C., Tan L., Lim L., Manser E. The mechanism of PAK activation. Autophosphorylation events in both regulatory and kinase domains control activity. J. Biol. Chem. 2001, 276:17347-17353.
6. Cline M.S., Smoot M., Cerami E., Kuchinsky A., Landys N., Workman C., Christmas R., Avila-Campilo I., Creech M., Gross B., et al. Integration of biological networks and gene expression data using Cytoscape. Nat. Protoc. 2007, 2:2366-2382.
7. Cox J., Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008, 26:1367-1372.
8. Cox J., Neuhauser N., Michalski A., Scheltema R.A., Olsen J.V., Mann M. Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 2011, 10:1794-1805.
9. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., Teague J., Woffendin H., Garnett M.J., Bottomley W., et al. Mutations of the BRAF gene in human cancer. Nature 2002, 417:949-954.
10. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol. Ther. 1992, 54:63-128.
11. Dinkel H., Chica C., Via A., Gould C.M., Jensen L.J., Gibson T.J., Diella F. Phospho.ELM: a database of phosphorylation sites-update 2011. Nucleic Acids Res. 2011, 39(Database issue):D261-D267.
12. Dougherty M.K., Müller J., Ritt D.A., Zhou M., Zhou X.Z., Copeland T.D., Conrads T.P., Veenstra T.D., Lu K.P., Morrison D.K. Regulation of Raf-1 by direct feedback phosphorylation. Mol. Cell 2005, 17:215-224.
13. Ehrenreiter K., Kern F., Velamoor V., Meissl K., Galabova-Kovacs G., Sibilia M., Baccarini M. Raf-1 addiction in Ras-induced skin carcinogenesis. Cancer Cell 2009, 16:149-160.
14. Geiger T., Wisniewski J.R., Cox J., Zanivan S., Kruger M., Ishihama Y., Mann M. Use of stable isotope labeling by amino acids in cell culture as a spike-in standard in quantitative proteomics. Nat. Protoc. 2011, 6:147-157.
15. Gould K.L., Hunter T. Platelet-derived growth factor induces multisite phosphorylation of pp60c-src and increases its protein-tyrosine kinase activity. Mol. Cell. Biol. 1988, 8:3345-3356.
16. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
17. Hanash S., Taguchi A. The grand challenge to decipher the cancer proteome. Nat. Rev. Cancer 2010, 10:652-660.
18. Harsha H.C., Pandey A. Phosphoproteomics in cancer. Mol. Oncol. 2010, 4:482-495.
19. Hornbeck P.V., Kornhauser J.M., Tkachev S., Zhang B., Skrzypek E., Murray B., Latham V., Sullivan M. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 2012, 40(Database issue):D261-D270.
20. Hummerich L., Müller R., Hess J., Kokocinski F., Hahn M., Fürstenberger G., Mauch C., Lichter P., Angel P. Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development. Oncogene 2006, 25:111-121.
21. Jørgensen C., Sherman A., Chen G.I., Pasculescu A., Poliakov A., Hsiung M., Larsen B., Wilkinson D.G., Linding R., Pawson T. Cell-specific information processing in segregating populations of Eph receptor ephrin-expressing cells. Science 2009, 326:1502-1509.
22. Krüger M., Moser M., Ussar S., Thievessen I., Luber C.A., Forner F., Schmidt S., Zanivan S., Fässler R., Mann M. SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function. Cell 2008, 134:353-364.
23. Kurzen H., Münzing I., Hartschuh W. Expression of desmosomal proteins in squamous cell carcinomas of the skin. J. Cutan. Pathol. 2003, 30:621-630.
24. Landis M.D., Seachrist D.D., Montañez-Wiscovich M.E., Danielpour D., Keri R.A. Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice. Oncogene 2005, 24:5173-5190.
25. Larsen M.R., Thingholm T.E., Jensen O.N., Roepstorff P., Jørgensen T.J. Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol. Cell. Proteomics 2005, 4:873-886.
26. Linding R., Jensen L.J., Ostheimer G.J., van Vugt M.A., Jørgensen C., Miron I.M., Diella F., Colwill K., Taylor L., Elder K., et al. Systematic discovery of in vivo phosphorylation networks. Cell 2007, 129:1415-1426.
27. Lu C., Li X.Y., Hu Y., Rowe R.G., Weiss S.J. MT1-MMP controls human mesenchymal stem cell trafficking and differentiation. Blood 2010, 115:221-229.
28. Mann M. Functional and quantitative proteomics using SILAC. Nat. Rev. Mol. Cell Biol. 2006, 7:952-958.
29. Marcotte R., Muller W.J. Signal transduction in transgenic mouse models of human breast cancer-implications for human breast cancer. J. Mammary Gland Biol. Neoplasia 2008, 13:323-335.
30. Marinkovich M.P. Tumour microenvironment: laminin 332 in squamous-cell carcinoma. Nat. Rev. Cancer 2007, 7:370-380.
31. Matsumoto T., Jiang J., Kiguchi K., Ruffino L., Carbajal S., Beltrán L., Bol D.K., Rosenberg M.P., DiGiovanni J. Targeted expression of c-Src in epidermal basal cells leads to enhanced skin tumor promotion, malignant progression, and metastasis. Cancer Res. 2003, 63:4819-4828.
32. Meves A., Geiger T., Zanivan S., DiGiovanni J., Mann M., Fässler R. Beta1 integrin cytoplasmic tyrosines promote skin tumorigenesis independent of their phosphorylation. Proc. Natl. Acad. Sci. USA 2011, 108:15213-15218.
33. Mi H., Dong Q., Muruganujan A., Gaudet P., Lewis S., Thomas P.D. PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucleic Acids Res. 2010, 38(Database issue):D204-D210.
34. Miller M.L., Jensen L.J., Diella F., Jørgensen C., Tinti M., Li L., Hsiung M., Parker S.A., Bordeaux J., Sicheritz-Ponten T., et al. Linear motif atlas for phosphorylation-dependent signaling. Sci. Signal. 2008, 1:ra2.
35. Molli P.R., Li D.Q., Murray B.W., Rayala S.K., Kumar R. PAK signaling in oncogenesis. Oncogene 2009, 28:2545-2555.
36. Monetti M., Nagaraj N., Sharma K., Mann M. Large-scale phosphosite quantification in tissues by a spike-in SILAC method. Nat. Methods 2011, 8:655-658.
37. Nilsson K., Svensson S., Landberg G. Retinoblastoma protein function and p16INK4a expression in actinic keratosis, squamous cell carcinoma in situ and invasive squamous cell carcinoma of the skin and links between p16INK4a expression and infiltrative behavior. Mod. Pathol. 2004, 17:1464-1474.
38. Nindl I., Dang C., Forschner T., Kuban R.J., Meyer T., Sterry W., Stockfleth E. Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling. Mol. Cancer 2006, 5:30.
39. Njar V.C., Gediya L., Purushottamachar P., Chopra P., Vasaitis T.S., Khandelwal A., Mehta J., Huynh C., Belosay A., Patel J. Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases. Bioorg. Med. Chem. 2006, 14:4323-4340.
40. Ohlrogge J., Allen D., Berguson B., Dellapenna D., Shachar-Hill Y., Stymne S. Energy. Driving on biomass. Science 2009, 324:1019-1020.
41. Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127:635-648.
42. Ong S.E., Blagoev B., Kratchmarova I., Kristensen D.B., Steen H., Pandey A., Mann M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1:376-386.
43. Ostasiewicz P., Zielinska D.F., Mann M., WiŚniewski J.R. Proteome, phosphoproteome, and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry. J. Proteome Res. 2010, 9:3688-3700.
44. Pawson T., Scott J.D. Protein phosphorylation in signaling-50 years and counting. Trends Biochem. Sci. 2005, 30:286-290.
45. Reddy E.P., Reynolds R.K., Santos E., Barbacid M. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 1982, 300:149-152.
46. Ridky T.W., Chow J.M., Wong D.J., Khavari P.A. Invasive three-dimensional organotypic neoplasia from multiple normal human epithelia. Nat. Med. 2010, 16:1450-1455.
47. Riker A.I., Enkemann S.A., Fodstad O., Liu S., Ren S., Morris C., Xi Y., Howell P., Metge B., Samant R.S., et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med. Genomics 2008, 1:13.
48. Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007, 131:1190-1203.
49. Ritt D.A., Monson D.M., Specht S.I., Morrison D.K. Impact of feedback phosphorylation and Raf heterodimerization on normal and mutant B-Raf signaling. Mol. Cell. Biol. 2010, 30:806-819.
50. Roberts S.J., Ng B.Y., Filler R.B., Lewis J., Glusac E.J., Hayday A.C., Tigelaar R.E., Girardi M. Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis. Proc. Natl. Acad. Sci. USA 2007, 104:6770-6775.
51. Roesch A., Becker B., Meyer S., Hafner C., Wild P.J., Landthaler M., Vogt T. Overexpression and hyperphosphorylation of retinoblastoma protein in the progression of malignant melanoma. Mod. Pathol. 2005, 18:565-572.
52. Schwartz D., Gygi S.P. An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat. Biotechnol. 2005, 23:1391-1398.
53. Siu M.K., Chan H.Y., Kong D.S., Wong E.S., Wong O.G., Ngan H.Y., Tam K.F., Zhang H., Li Z., Chan Q.K., et al. p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients. Proc. Natl. Acad. Sci. USA 2010, 107:18622-18627.
54. Stratton M.R., Campbell P.J., Futreal P.A. The cancer genome. Nature 2009, 458:719-724.
55. Szklarczyk D., Franceschini A., Kuhn M., Simonovic M., Roth A., Minguez P., Doerks T., Stark M., Muller J., Bork P., et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011, 39(Database issue):D561-D568.
56. Tian Q., Stepaniants S.B., Mao M., Weng L., Feetham M.C., Doyle M.J., Yi E.C., Dai H., Thorsson V., Eng J., et al. Integrated genomic and proteomic analyses of gene expression in Mammalian cells. Mol. Cell. Proteomics 2004, 3:960-969.
57. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 2001, 98:5116-5121.
58. Villén J., Beausoleil S.A., Gerber S.A., Gygi S.P. Large-scale phosphorylation analysis of mouse liver. Proc. Natl. Acad. Sci. USA 2007, 104:1488-1493.
59. Walrath J.C., Hawes J.J., Van Dyke T., Reilly K.M. Genetically engineered mouse models in cancer research. Adv. Cancer Res. 2010, 106:113-164.
60. Wang L., Harris T.E., Lawrence J.C. Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation. J. Biol. Chem. 2008, 283:15619-15627.
61. Wisniewski J.R., Zougman A., Nagaraj N., Mann M. Universal sample preparation method for proteome analysis. Nat. Methods 2009, 6:359-362.
62. Wong M.P., Cheang M., Yorida E., Coldman A., Gilks C.B., Huntsman D., Berean K. Loss of desmoglein 1 expression associated with worse prognosis in head and neck squamous cell carcinoma patients. Pathology 2008, 40:611-616.
63. Yu H., Mouw J.K., Weaver V.M. Forcing form and function: biomechanical regulation of tumor evolution. Trends Cell Biol. 2011, 21:47-56.
64. Zaidel-Bar R., Geiger B. The switchable integrin adhesome. J. Cell Sci. 2010, 123:1385-1388.
65. Zanivan S., Gnad F., Wickström S.A., Geiger T., Macek B., Cox J., Fässler R., Mann M. Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry. J. Proteome Res. 2008, 7:5314-5326.
66. Zanivan S., Krueger M., Mann M. In vivo quantitative proteomics: the SILAC mouse. Methods Mol. Biol. 2012, 757:435-450.